Title-loss of βcatenin is an independent prognostic factor in ovarian carcinomas: A multivariate analysis Research Article
|
|
- Elijah Cain
- 5 years ago
- Views:
Transcription
1 Gene Therapy and Molecular Biology Vol 10, page 179 Gene Ther Mol Biol Vol 10, , 2006 Title-loss of βcatenin is an independent prognostic factor in ovarian carcinomas: A multivariate analysis Research Article Cristina Faleiro-Rodrigues 1, *, Isabel Macedo-Pinto 1, Deolinda Pereira 2 1 Department of Anatomy and Pathology 2 Department of Medical Oncology, Portuguese Institute of Oncology of Francisco Gentil, Centro Regional do Norte, Porto, Portugal *Correspondence: Faleiro-Rodrigues C., Instituto Português de Oncologia Francisco Gentil, Centro Regional do Norte, Departamento de Anatomia Patológica, Rua Dr. António Bernardino de Almeida Porto, Portugal; Telephone: Ext 1002; Fax ; cristinafaleiro@mail.com Key words: ovarian cancer, cell adhesion, epithelial cadherin, β-catenin, immunohistochemistry Abbreviations: avidin-biotin peroxidase, (ABC); E-cadherin catenin unit, (ECCU); Epithelial cadherin, (E-cadherin); International Federation of Gynaecology and Obstetrics system, (FIGO); Overall survival, (OS); World Health Organization, (WHO) Received: 10 March 2006; Revised: 26 April 2006 Accepted: 16 May 2006; electronically published: July 2006 Summary In ovarian carcinomas, numerous studies have shown consistent prognostic significance of FIGO stage and residual tumour as independent prognostic factors. However, these prognostic factors alone cannot accurately predict disease outcome since a considerable degree of heterogeneity remains within the various subgroups limiting the predictive value of these factors. Therefore, the identification of new molecular markers that may possibly distinguish patients at a higher risk is of great importance. In two previous studies, the individual loss of E-cadherin and the individual loss of β-catenin were important prognostic factors of poorer overall survival in patients with ovarian carcinomas. Purpose of the present study was to re-analyse the immunohistochemical expression of E- cadherin and β-catenin in 104 patients with ovarian carcinomas, and evaluate whether these two proteins continue to be important independent prognostic factors when assessed together in a multivariate Cox s proportional hazard regression analysis. Results In the multivariate analysis, the most important independent prognostic factors of poorer overall survival were loss of β-catenin expression ([HR], 5.79, 95% CI, 2.38 to 14.10; P=0.0001), FIGO stage IV ([HR], 7.19, 95% CI, 1.02 to 50.8; P=0.04) and residual tumour ([HR], 6.78, 95% CI, 1.41 to 32.56; P=0.034). Conclusion The loss of β-catenin expression is a stronger prognostic factor than E-cadherin. The findings in the present study and previously reported data suggest that β-catenin is a significant prognostic indicator in patients with epithelial ovarian cancer, however, these results should be supported by more and larger studies. I. Introduction In ovarian carcinomas, numerous studies have shown consistent prognostic significance of FIGO tumour stage and size of residual tumour as independent prognostic factors (Rubin et al, 2003). However, these prognostic factors alone cannot accurately predict disease outcome since a considerable degree of heterogeneity remains within the various subgroups limiting the predictive value of these factors. Therefore, the identification of new molecular markers that may possibly distinguish patients at a higher risk is of great importance. Epithelial cadherin (E-cadherin) is a calcium-dependent cell adhesion molecule which plays a key role in cell-cell epithelial adhesion and epithelial tissue integrity. The intracellular domain of E-cadherin is found in a complex linked with the catenins (α-and β-). The association of catenins to cadherins is a key step in the function of intact adhesion complexes. The catenins link the cadherin molecules to the cytoskeleton and mediate signal transduction mechanisms that regulate cell adhesion, growth and differentiation (Frixen et al, 1991; Tsukita et al, 1992; Kemler, 1993; Hinck et al, 1994). Detachment of tumour cells from the primary lesion is considered a main step in the process of invasion and metastases. Increasing evidence points to a role for E-cadherin and the catenins in cancer progression since the loss or reduced expression of E-cadherin and β- 179
2 Faleiro-Rodrigues et al: Loss of β catenin expression in primary ovarian carcinomas catenin correlates with invasive behaviour, increased lymph node metastasis and poor outcome in patients with malignant melanoma and gastric carcinomas (Jawhari et al, 1997; Ramesh et al, 1999; Kageshita et al, 2001; Tanaka et al, 2002). In two previous individual studies, a significant correlation between poor overall survival and the loss of E-cadherin and the loss of β-catenin was observed in patients with ovarian carcinomas. The loss of E-cadherin and β-catenin immunoexpression was also shown to be independent predictors of poorer survival in a multivariate analysis (Faleiro-Rodrigues et al 2004a, b). This study represents a re-analyse of previously published data with the purpose of determining whether these two proteins continue to be important independent prognostic factors when assessed together in a multivariate Cox s proportional hazard regression analysis. II. Material and Methods Routinely formalin-fixed and paraffin-embedded tissue samples from 104 cases of primary ovarian carcinomas were retrieved from the Department of Pathology at the Portuguese Institute of Oncology of Francisco Gentil, Porto, from January 1995 to December The mean age at the time of diagnosis was 56 years (range, 21 to 89 years). None of these patients had undergone neoadjuvant chemotherapy prior to surgery. All tissue specimens were reviewed and re-evaluated by an experienced gynaecological pathologist. Histological classification was performed according to the World Health Organization (WHO) standards. The grading and staging of the tumours were assigned according to the International Federation of Gynaecology and Obstetrics system (FIGO). The mean overall survival duration of the patients was 35 months. At the end of the follow-up period, 65 (62%) patients were without evidence of disease, 35 (34%) patients had died of disease, and 4 (4%) patients were lost for follow up. A. Tissue sections All the tissue sections (stained by haematoxylin and eosin) from each case were observed. Areas of necrosis or deterioration of tissue morphology were avoided. The pathologist selected the best tumour section representing well preserved tissue architecture and cell morphology with approximately 2.0 x 1.0 cm. B. Immunohistochemical staining Archival tissue was fixed in 10% formalin and 3 µm sections were used for both histological and immunohistochemical studies. Immunohistochemistry was performed in all cases using the avidin-biotin peroxidase (ABC) complex with an additional step for microwave antigen retrieval as described (Faleiro-Rodrigues et al, 2004b). The following monoclonal antibodies were used: E-cadherin (C20820), and β- catenin (C19220) (Transduction Laboratories, Lexington, UK). To ensure accurate and reproducible staining, normal skin epithelium was used as a positive control. Staining of E-cadherin and β-catenin was localized on the cell membrane of epithelial cells, particularly at areas of cell-tocell contact. Normal skin epithelium without the primary antibody was used as a negative control. C. Evaluation of E-cadherin and β-catenin immunostaining Membranous immunoreactivity of the catenins was assessed by light microscopy by two independent observers, without previous knowledge of the patients clinicopathological details. E-cadherin and β-catenin immunoexpression in the tumours was scored semi-quantitatively on a scale of 0 to 3 (0=complete absence of expression, 1=10%, 2 >10 and = 50%, 3 >50%). For all the association analyses, the subdivision into negative (0 scale) and positive expression (1-3 scale) was used. D. Statistical analysis The statistical software used was the Statistical Package for the Social Sciences (SPSS version 8.0, SPSS, Chicago). Clinical data was obtained from the Cancer Registry Records of the patients and evaluated by a Medical Oncologist. Overall survival (OS) was defined as the time from diagnosis to death or last clinical control date, and used as a measure of prognosis. Univariate survival curves were estimated using the Kaplan- Meier method and compared using the Log-rank or the Breslow test. Multivariate analysis was performed using the Cox s proportional hazards regression model with overall survival as the outcome measure. Forward stepwise procedure was used to select the independent variables in the multivariate analysis. Forward selection, allows variables to be considered one at a time for entry into the model. After a variable is added to the model, all variables already in the model are examined for removal. The algorithm stops when no more variables meet entry or removal criteria. A value of P<0.05 was regarded as significant. III. Results The present series consisted of 104 carcinomas that were classified into the following histological types, 56 serous carcinomas, 22 mucinous carcinomas, 16 clear cell carcinomas, 8 endometrioid and 2 transitional cell carcinomas. These carcinomas were graded into 26 welldifferentiated, 27 moderately differentiated and 51 poorly differentiated tumours. In this series, 31 cases were diagnosed with FIGO stage I tumours, 7 in FIGO stage II, 47 in FIGO stage III and 19 in FIGO stage IV. The clinicopathological parameters studied were FIGO staging, histological type, tumour differentiation, peritoneal metastasis, and residual tumour after surgery, the appearance of the ovarian capsule, peritoneal cytology and lymphatic/vascular invasion (previously described in Faleiro-Rodrigues et al 2004a). A. Immunoreactivity of E-cadherin and β-catenin in carcinoma tissue Negative E-cadherin expression was observed in 7 (7%) malignant tumours, and positive in 97 (93%). Negative β-catenin expression was observed in 15 (14%) malignant tumours, and positive in 89 (86%). B. Relationship between E-cadherin and β-catenin expression in carcinoma tissue In the 15 carcinomas demonstrating negative expression for β-catenin, 3 carcinomas showed negative expression for E-cadherin, and 12 carcinomas showed positive expression for E-cadherin (Table 1). C. Relationship between the expression of E-cadherin and β-catenin and patient overall survival 180
3 Gene Therapy and Molecular Biology Vol 10, page 181 In the univariate survival analysis, patients whose carcinoma tissue demonstrated negative E-cadherin expression had a statistically significant decreased 5-year overall survival rate compared with patients showing positive expression (29% versus 66%, P=0.006), (Faleiro- Rodrigues et al, 2004a). Patients whose carcinoma tissue demonstrated negative β-catenin expression had a statistically significant decreased 5-year overall survival rate compared with patients showing positive expression (44% versus 66%, P=0.022), (Faleiro-Rodrigues et al, 2004b). The parameters that had a significant impact on overall survival as E-cadherin (P=0.006), β-catenin (P=0.022), FIGO stage (P ), peritoneal metastasis (P ), and post-operative residual tumour (P ), peritoneal cytology (P ) and lymphatic/vascular invasion (P=0.008), were then reviewed by a multivariate analysis (Cox s proportional hazards regression model, Table 2). Negative expression of β-catenin (P=0.0001); (Figure 1), FIGO stage IV (P=0.04) and residual postoperative tumour (P=0.01) were shown to associate significantly with poor patient prognosis. IV. Discussion The cause of epithelial ovarian carcinoma is unknown and diagnosis is retarded by the lack of symptoms in early stage disease. Consequently, the poor overall survival and morbidity associated with epithelial ovarian cancer deaths results from the detection of the disease in advanced tumour stages with widespread metastatic disease at the time of diagnosis (Ozols et al, 2000). To date, the molecular mechanisms that allow ovarian cancer cells to detach from the primary tumour and consequently interact with the mesothelium are not fully characterized. Cell adhesion molecules may play an important role in epithelial ovarian carcinogenesis, since cell-to-cell adhesion plays a critical role in a wide variety of biological processes including embryogenesis, maintenance of cell polarity, cell growth, and cell differentiation (Skubitz, 2002). The loss of cell adhesion molecules may lead to changes in cellular adhesion and to increased motility, processes that contribute to the invasive and/or metastatic potential of cells (Vleiminckx et al, 1991; Birchmeier and Behrens, 1993; Mareel et al, 1994; Van Aken et al, 2001). E-cadherin has been identified as an important transmembrane molecule involved in the adhesion of epithelial cells at adherens junctions. Adherens junctions are organized around transmembrane proteins of the cadherin family. While the extracellular domain of the E- cadherin molecule interacts with that of an opposing E- cadherin on a neighbouring cell, the intracellular cytoplasmic domain of E-cadherin associates with ß- catenin, which in turn complexes with α-catenin mediating the connection of E-cadherin to the cytoskeleton (Tsukita et al, 1992). The complex of E-cadherin and the Table 1. Relationship between E-cadherin and β-catenin expression in ovarian carcinomas Table 2. Multivariate analysis for overall survival Immunoexpression Nº β-catenin Negative Positive E-cadherin Negative Positive Total Covariate Hazard ratio (95% CI) P value I 1 II 5.58 ( ) III 2.99 ( ) IV 7.19 ( ) Residual tumour (-) 1 (+) 6.78 ( ) β-catenin (+) 1 (-) 5.79 ( )
4 Faleiro-Rodrigues et al: Loss of β catenin expression in primary ovarian carcinomas Figure 1. Immunoreactivity of β-catenin (A) Negative expression, (B) Mucinous carcinoma showing positive ß-catenin expression. catenins is a functional unit, which is termed here as the E- cadherin-catenin unit (ECCU). Binding to catenins is important for E-cadherin function, rendering the catenins regulatory molecules of E-cadherin. Thus, alterations in E- cadherin or the catenins may lead to loss of cell-cell adhesion, resulting in tumour aggressiveness and invasiveness in neoplastic disease (Ozawa et al, 1990; Frixen et al, 1991; Mareel et al, 1994). In two previous individual studies, the significance of E-cadherin and the catenins α, β- and γ-, as predictors of poorer survival in patients with ovarian carcinomas was assessed. The first study showed that negative E-cadherin immunoexpression significantly predicted a poorer overall survival, and was an independent prognostic factor in the multivariate analyses (Faleiro-Rodrigues et al 2004a). In the second study, although negative immunoexpression of α-catenin and γ-catenin was observed, only negative β- catenin expression was associated with patient poorer overall survival in the univariate analyses. In the multivariate analysis, β-catenin immunoexpression and residual tumour were shown to be independent prognostic factors for survival (Faleiro-Rodrigues et al 2004b). In the present study, when E-cadherin and β-catenin were assessed together in a Cox s multivariate regression analysis to determine whether the immunoexpression of these two proteins continued to be independent prognostic factors, only β-catenin continued to be an independent prognostic factor of poor survival. The loss of β-catenin expression, FIGO stage IV and residual tumour, when considered with parameters that had a significant impact on overall survival as peritoneal metastasis, peritoneal cytology, lymphatic/vascular invasion and E-cadherin expression, were shown to be the strongest independent predictors of poor survival. The results of this study suggest that when β-catenin and E-cadherin are assessed in a multivariate analysis, the loss of β-catenin proves to be a more important prognostic marker than the loss of E- cadherin in patients with ovarian carcinomas. A study by the group of Akimoto et al, showed that the expression of E-cadherin in murine adenocarcinomas correlated well with the expression of β-catenin. They also showed that reduced expression of β-catenin in these tumours correlated with enhanced metastasis formation (Akimoto et al, 1999). Whether β-catenin alone could have affected the propensity of these tumour cells to metastasise is unclear. However, some recent studies show an independent role of the catenins in tumour invasion and metastases (Kawanishi et al, 1995; Vermeulen et al, 1995). Studies on the molecular organization of the ECCU using recombinant proteins have demonstrated β-catenin to play a central role in the formation of the E-cadherin complex (Oyama et al, 1994; Kawanishi et al, 1995; Vermeulen et al, 1995; Harington and Syrigos, 2000). In general, adhesion between normal epithelial cells is strong and stable. For tumour cells to dissociate, invade and metastasize, cell-to-cell associations must be disrupted. In our series of ovarian carcinomas, despite the small number of tumours showing loss of expression for β-catenin the observation that a) 15 carcinomas demonstrated negative expression for β-catenin, of which 3 were negative and 12 were positive for E-cadherin, respectively, and b) β- catenin expression was shown to be an independent prognostic factor in a previous (Faleiro-Rodrigues et al 2004b) and in the present study, reinforces the viewpoint that β-catenin is a crucial and indispensable component in the formation of the ECCU, and that loss of β-catenin alone may be sufficient to disassemble the adherent junction, leading to loss of intercellular adhesion. Thus, loss of β-catenin expression may be an important step in the development of a malignant tumour, by this approach, enable the dissociation of cells from the primary tumour, and thus possibly contribute to tumour cell invasion and tumour peritoneal implantation in ovarian cancer patients. Although the prognostic value of β-catenin needs to be supported by more studies and a larger number of patients, this retrospective study, suggests that the immunohistochemical assessment of β-catenin into negative versus positive expression on primary ovarian carcinomas may prove to be a useful marker for selecting 182
5 Gene Therapy and Molecular Biology Vol 10, page 183 a small group of patients with a high risk of suffering an unfavourable clinical outcome. Whether this information can be used to stratify patients for therapeutic strategies also needs to be explored in future clinical studies. In several carcinomas, loss of β-catenin expression by immunohistochemistry has been associated with malignant transformation as increased invasiveness, disease progression, and poor prognosis (Takayama et al, 1996; Jawhari et al, 1997; Muzio et al, 1999; Ramesh et al, 1999; Garcia del Muro et al, 2000; Kageshita et al, 2001; Tanaka et al, 2002). However, the molecular mechanisms that bring about the loss of β-catenin in these tumours have not been characterized and yet to be investigated. The causal mechanism for the loss of β-catenin protein expression in our series of ovarian carcinomas is not clear. Several mechanisms may impair β-catenin from being expressed, such as hypermethylation of the β-catenin gene (CTNNB1) promoter, CTNNB1 mutations and deletions (Ebert et al, 2003; Ueda et al, 2001). It is now of interest to evaluate further the molecular mechanisms that underlie the observed loss of β-catenin observed in the present study. Future investigations on the regulation of the expression of β-catenin may elucidate possible mechanisms resulting in the loss of this protein. Nevertheless, irrespective of the mechanism that impairs the expression of β-catenin, based on the above results, it seems that tumour cells may become increasingly invasive and show an aggressive cellular phenotype upon the loss of β-catenin, which may be an important step in the progression of ovarian carcinomas. In conclusion, these findings suggest that β-catenin immunoexpression may assist in the identification of a group of patients who run a higher risk of an unfavourable disease outcome, and may be a useful prognostic marker for the clinical assessment of epithelial ovarian cancer complementary to other established prognostic factors as FIGO tumour stage and residual tumour. It should be noted that these results need be supported by more studies and a larger number of patients. Acknowledgements This project was supported by a Ph.D. grant PRAXIS XXI/BD/9615/96 from the Foundation of Science and Technology (FCT). References Akimoto T, Kawabe S, Grothey A, Milas L (1999) Low E- cadherin and β-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas. Clin Exp Metastasis 17, Birchmeier W, Behrens J (1993) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198, Ebert MP, Yu J, Hoffmann J, Rocco A, Rocken C, Kahmann S, Muller O, Korc M, Sung JJ, Malfertheiner P (2003) Loss of β-catenin expression in metastatic gastric cancer. J Clin Oncol 21, Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Lopes CS (2004a) Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas. Ann Oncol 15, Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Lopes CS (2004b) Loss of β-catenin, is associated with poor survival in ovarian carcinomas. Int J Gynecol Pathol 23, Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) Ecadherin mediated cellcell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113, Garcia del Muro X, Torregrosa A, Munoz J, Castellsague X, Condom E, Vigues F, Arance A, Fabra A, Germa JR (2000) Prognostic value of expression of E-cadherin and β-catenin in bladder cancer. Eur J Cancer 36, Harington KJ, Syrigos KN (2000) The role of E-cadherin-catenin complex: more than an intercellular glue? Ann Surg Oncol 7, Hinck L, Näthke IS, Papkoff J, Nelson WJ (1994) Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 125, Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ (1997) Abnormal immunoreactivity of the E-cadherincatenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112, Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T (2001) Loss of β-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 145, Kawanishi J, Kato J, Sasaki K, FujiisS, Watanabe N, Niitsu Y (1995) Loss of E-cadherin dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line HSC-39. Molecular Cell Biol 15, Kemler R (1993) From cadherins to catenins: cytoplasmatic protein interactions and regulation of cell adhesion. Trends Genetics 9, Lo Muzio LL, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa NF, De Rosa G (1999) β and γ-catenin expression in oral squamous cell carcinoma. Anticancer Res 19, Mareel M, Bracke M, Van Roy F (1994) Invasion promoter versus invasion suppressor molecules: the paradigm of E- cadherin. Mol Biol Rep 19, Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanigihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F et al (1994) A truncated β-catenin disrupts the interaction between E- Cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54, Ozawa M, Ringwald M, Kemler R (1990) Uvomorulin-catenin complex formation is regulated by aspecific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 87, Ozols RF, Rubin SC, Thomas GM, Robboy SJ (2000) Epithelial ovarian cancer. In Hoskins W J, Perez CA, Young RC (eds.): Principles and Practice of Gynecologic Oncology, 3rd edition. Philadelphia: PA: Lippincott Williams & Wilkins; Ramesh S, Nash J, McCulloch PG (1999) Reduction in membranous expression of β-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 81, Rubin SC, Sabbatini P, Randall ME (2002) Ovarian Cancer. In: Pazdur R, Coia LR, Hoskins W J,Wagman LD (eds): Cancer Management: A Multidisciplinary Approach, 3rd edition Skubitz APN (2002) Adhesion molecules. Cancer Treat Res 107,
6 Faleiro-Rodrigues et al: Loss of β catenin expression in primary ovarian carcinomas Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M (1996) β- catenin expression in human cancers. Am J Pathol 148, Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K (2002) Abnormal expression of E-cadherin and β-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surgery 89, Tsukita S, Tsukita S, Nagafuchi A, Yonemura S (1992) Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr Opin Cell Biol 4, Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabkin HA (2001) Mutations of the β- and γ- catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85, Van Aken E, De Wever O, Correia da Rocha AS, Mareel M (2001) Defective E-cadherin/catenincomplexes in human cancer. Virchows Archn 439, Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM (1995) Transition from the noninvasive to the invasive phenotype and loss of β-catenin in human colon cancer cells. Cancer Res 55, Vleiminckx K, Vakaet l Jr, Mareel M, Fiers W, Van Roy F (1991) Genetic manipulation of E-Cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, Cristina Faleiro-Rodrigues 184
Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,
More informationE-Cadherin Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Bladder After Transurethral Resection
UROLOGICAL ONCOLOGY E-Cadherin Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Bladder After Transurethral Resection Mohammad Hatef Khorrami, Mazaher Hadi, Mohammad Reza Gharaati,
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More informationRoles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma
EXPERIMENTAL AND THERAPEUTIC MEDICINE 6: 1489-1493, 2013 Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma JINQUAN CAI Department of Urology, Fuzhou
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/24096
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationRole of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters
Naz et al. World Journal of Surgical Oncology (2015) 13:315 DOI 10.1186/s12957-015-0732-1 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Role of peritoneal washing in ovarian malignancies: correlation
More informationClinical statistics of gynecologic cancers in Japan
J Gynecol Oncol. 2017 Mar;28(2):e32 pissn 2005-0380 eissn 2005-0399 Review Article Clinical statistics of gynecologic cancers in Japan Wataru Yamagami, 1,7 Satoru Nagase, 2,7 Fumiaki Takahashi, 3 Kazuhiko
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationMolecular Pathology of Ovarian Carcinoma with Morphological Correlation
Molecular athology of Ovarian Carcinoma with Morphological Correlation Kathleen R. Cho, M.D. Comprehensive Cancer Center and Departments of athology and Internal Medicine University of Michigan Medical
More informationThe E-Cadherin Expression vs. Tumor Cell Proliferation Paradox in Endometrial Cancer
The E-Cadherin Expression vs. Tumor Cell Proliferation Paradox in Endometrial Cancer IRENE GONZÁLEZ-RODILLA 1, LAURA ALLER 2, JAVIER LLORCA 3, ANA-BELÉN MUÑOZ 2, VIRGINIA VERNA 2, JOSÉ ESTÉVEZ 2 and JOSÉ
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationDifferentiation of Tumors with Specific Red Cell Adherence (SRCA) test
753 Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test Dr. Abhishek A Mangaonkar *, Dr. A G Valand 1 Intern, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India 2 Professor,
More informationApplications of IHC. Determination of the primary site in metastatic tumors of unknown origin
Applications of IHC Determination of the primary site in metastatic tumors of unknown origin Classification of tumors that appear 'undifferentiated' by standard light microscopy Precise classification
More informationPatterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma
Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma Hadia. Mohammed. Abdalla. Abdalrhman *, Elsadig.A.Adam, Ayda.D.A.Allatif 3,'Namareg.E.Afadul
More informationEvaluation of p53, PTEN and β-catenin Immunoexpressions in Primary Ovarian Epithelial Tumors
Original Article Middle East Journal of Cancer; July 2015; 6(3): 135-142 Evaluation of p53, PTEN and β-catenin Immunoexpressions in Primary Ovarian Epithelial Tumors Fatemeh Sari Aslani*, Azarmidokht Momeni*,
More informationAssociation between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer
James et al. BMC Cancer (2017) 17:657 DOI 10.1186/s12885-017-3585-x RESEARCH ARTICLE Open Access Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian
More informationB eta catenin was first identified as a protein associated
347 ORIGINAL ARTICLE Nuclear b catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong S C C Wong, E S F Lo, A K C Chan, K C Lee, W L Hsiao... See end
More informationCoordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma
Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,
More informationPerfiles de expresión génica y nuevas dianas terapéuticas en cáncer de endometrio
Perfiles de expresión génica y nuevas dianas terapéuticas en cáncer de endometrio Curso Corto Actualización en Patología Ginecológica David Hardisson Departamento de Anatomía Patológica CA. DE ENDOMETRIO
More informationImmunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors.
ISPUB.COM The Internet Journal of Pathology Volume 13 Number 2 Immunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors. A Baghla, S Choudhry, A Kataria Citation A Baghla, S Choudhry,
More informationTitle: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen
Author's response to reviews Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen Authors: Caiyun Liu (liucaiyun23@yahoo.com.cn) Bin Dong
More informationINTRODUCTION Ovarian cancer is the leading cause of mortality from gynecologic malignancies in the industrialized countries and is responsible for
INTRODUCTION Ovarian cancer is the leading cause of mortality from gynecologic malignancies in the industrialized countries and is responsible for more deaths than both cervical and endometrial tumours.
More informationResearch Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
SAGE-Hindawi Access to Research International Breast Cancer Volume 20, Article ID 47957, 4 pages doi:0.406/20/47957 Research Article Stromal Expression of CD0 in Invasive Breast Carcinoma and Its Correlation
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationIs Desmoplasia a Protective Factor for Survival in Patients With Colorectal Carcinoma?
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:370 375 Is a Protective Factor for Survival in Patients With Colorectal Carcinoma? ALESSANDRO CAPORALE,* ANNA RITA VESTRI, EUGENIO BENVENUTO,* MAURO MARIOTTI,
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationCurrent Concept in Ovarian Carcinoma: Pathology Perspectives
Current Concept in Ovarian Carcinoma: Pathology Perspectives Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine Current Concept in Ovarian
More informationIntroduction to REMARK: Reporting tumour marker prognostic studies
Introduction to REMARK: Reporting tumour marker prognostic studies Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK C 1 S M Reliable research Reliability is determined by proper
More informationStudy on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value
Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Shen Wei 1,a, Chen Juan 2, Li Xiurong 1 and Yin Jie 1 1 Department of Obstetrics and Gynecology,
More informationCD15 and CEA expression in thymic epithelial neoplasms
Turkish Journal of Cancer Volume 8, No., 8 CD and CEA expression in thymic epithelial neoplasms AYTEKİN AKYOL, AYŞEGÜL ÜNER Hacettepe University, Department of Pathology, Ankara-Turkey ABSTRACT The aim
More informationSignificance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma
ORIGINAL STUDY Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma Jeong-Yeol Park, MD, PhD, Dae-Yeon Kim, MD, PhD, Dae-Shik Suh, MD, PhD, Jong-Hyeok Kim, MD, PhD, Yong-Man
More informationCorrelation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia
Cancer Research Journal 2016; 4(3): 43-47 http://www.sciencepublishinggroup.com/j/crj doi: 10.11648/j.crj.20160403.11 ISSN: 2330-8192 (Print); ISSN: 2330-8214 (Online) Correlation Between GATA-3, Ki67
More informationAn Example of Business Analytics in Healthcare
An Example of Business Analytics in Healthcare Colleen McGahan Biostatistical Lead Cancer Surveillance & Outcomes BC Cancer Agency cmcgahan@bccancer.bc.ca Improve Ovarian Cancer Outcomes Business relevancy
More informationIn vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG)
In vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG) 1 Dr Saeb Aliwaini 13/11/2015 Migration in vivo Primary tumors are responsible for only about 10%
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationPrognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk
843 Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk Tadashi Hasegawa, M.D. 1 Seiichiro Yamamoto, Ph.D. 2
More informationHPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa
Romanian Journal of Morphology and Embryology 2005, 46(2):155 159 HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa CRISTIANA SIMIONESCU 1), CL. MĂRGĂRITESCU 1), CLAUDIA
More informationDetection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma
The Journal of International Medical Research 2012; 40: 293 299 [first published online ahead of print as 40(1) 3] Detection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationT he Role of E-cadherin/β-catenin Complex and Cyclin D1 in Head and N eck Squamous Cell Carcinoma
Cancer Research and Treatment 2004;36(1):72-78 T he Role of E-cadherin/β-catenin Complex and Cyclin D1 in Head and N eck Squamous Cell Carcinoma Nam Yong Do, M.D., Ph.D. 1, Sung Yong Park, M.D. 1 and Sung
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationfollowing radiotherapy
British Journal of Cancer (1995) 72, 1536-154 r) 1995 Stockton Press All rights reserved 7-92/95 $12. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy ARM Sproston',
More informationLow-grade serous neoplasia. Robert A. Soslow, MD
Low-grade serous neoplasia Robert A. Soslow, MD soslowr@mskcc.org Outline Orientation Ovarian tumor overview Non serous borderline tumors Serous borderline tumors Clinical summary Morphologic description
More informationLoss of E-cadherin and Acquisition of Vimentin in Epithelial- Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
The Korean Journal of Pathology 2012; 46: 341-348 ORIGINAL ARTICLE Loss of E-cadherin and Acquisition of Vimentin in Epithelial- Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
More informationRCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer
JBUON 2019; 24(2): 715-719 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE RCD24, B7-H4 and PCNA expression and clinical significance in ovarian
More informationPrimary Cutaneous Apocrine Carcinoma of Sweat Glands: A Rare Case Report
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationE-Cadherin and -Catenin Expression in Normal, Inflamed and Cancerous Gallbladder Tissue
E-Cadherin and -Catenin Expression in Normal, Inflamed and Cancerous Gallbladder Tissue HARALD PUHALLA 1, BEATE HERBERGER 1, AFSCHIN SOLEIMAN 3, MARTIN FILIPITS 2, FRITZ LAENGLE 1, THOMAS GRUENBERGER 1
More informationAdjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals
6 Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 0-year Survivals V Sivanesaratnam,*FAMM, FRCOG, FACS Abstract Although the primary operative mortality following radical hysterectomy
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationClinical Study The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs between Rectal and Colon Carcinoma
Gastroenterology Research and Practice Volume 2010, Article ID 616023, 7 pages doi:10.1155/2010/616023 Clinical Study The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More informationexpression in moderately differentiated Dukes' B
2181 JClin Pathol 1997;50:218-222 Colorectal Cancer Unit, Imperial Cancer Research Fund, HAI 3UJ M Ilyas I C Talbot Cancer Genetics Laboratory, Imperial Cancer Research Fund 44 Lincoln's Inn Fields, London
More informationIntra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer
Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical
More informationChibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article
Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile
More informationXXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology
XXV Congreso de la Sociedad Española de Anatomía Patológica y División Española de la International Academy of Pathology NUEVOS FENOTIPOS DEL CÁNCER DE MAMA: NUEVOS PROBLEMAS PARA EL PATÓLOGO? Tienen actualmente
More informationACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION
POL J PATHOL 2011; 2: 95-100 ACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION OF MALIGNANT PLEURAL AND PERITONEAL EFFUSIONS FERESHTEH ENSANI, FARNAZ NEMATIZADEH, GITI IRVANLOU Department of Cytology, Cancer
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY Methodology The test is based on the reported 50-gene classifier algorithm originally named PAM50 and is performed on the ncounter Dx Analysis System
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY GENE EXPRESSION PROFILING WITH PROSIGNA What is Prosigna? Prosigna Breast Cancer Prognostic Gene Signature Assay is an FDA-approved assay which provides
More informationEvaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters
IJHOSCR International Journal of Hematology-Oncology and Stem Cell Research Original Article Evaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters
More informationPodocalyxin-like protein as a prognostic marker in colorectal cancer: Functional studies and clinical implication
Podocalyxin-like protein as a prognostic marker in colorectal cancer: Functional studies and clinical implication Karin Jirström Professor, Pathology Lund University, Regional Laboratories Region Skåne
More informationPrognostic significance of nemo like kinase in nasopharyngeal carcinoma
MOLECULAR MEDICINE REPORTS 10: 131-136, 2014 Prognostic significance of nemo like kinase in nasopharyngeal carcinoma SIZE CHEN 1,2*, ZHIJIAN MA 3*, XUEMEI CHEN 4 and JIREN ZHANG 1 1 Department of Oncology,
More informationModified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
British Journal of Cancer (2011) 105, 698 708 All rights reserved 0007 0920/11 www.bjcancer.com Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationAnnual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
More informationUpper urinary tract urothelial carcinomas (UTUC)
Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract Manel Mellouli 1 *, Slim Charfi 1, Walid Smaoui 2, Rim Kallel 1, Abdelmajid Khabir 1, Mehdi Bouacida
More informationGeorge Deeb 1,2, Jianmin Wang 3, Nithya Ramnath 3, Harry K Slocum 1,2, Sam Wiseman 4, Amy Beck 1,2,3,4 and Dongfeng Tan 1,2,3,4
& 2004 USCAP, Inc All rights reserved 0893-3952/04 $25.00 www.modernpathology.org Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer:
More informationHow to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens
How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens Wenxin Zheng, M.D. Professor of Pathology and Gynecology University of Arizona zhengw@email.arizona.edu http://www.zheng.gynpath.medicine.arizona.edu/index.html
More informationOvarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center
Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationCase presentation 04/13/2017. Genomic/morphological classification of endometrial carcinoma
Genomic/morphological classification of endometrial carcinoma Robert A. Soslow, MD soslowr@mskcc.org architecture.about.com Case presentation 49 year old woman with vaginal bleeding Underwent endometrial
More informationRESEARCH ARTICLE. Masaki Tomita 1, Takanori Ayabe 1, Eiichi Chosa 1, Naohiro Nose 1, Kunihide Nakamura 2 * Abstract. Introduction
RESEARCH ARTICLE Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer Masaki Tomita 1, Takanori
More informationJun Lu, Chang-Ming Huang, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, and Jian-Xian Lin
Oncology Volume 22, Article ID 6428, 7 pages doi:.55/22/6428 Research Article Analysis on the Clinical and Pathological Features and Prognosis of Familial Gastric Cancer in South China Population: A Single-Center
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationRisk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer
498 Original article Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer Authors C. Kunisaki 1, M. Takahashi 2, Y. Nagahori 3, T. Fukushima 3, H. Makino
More informationThe role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
Radiology and Oncology Ljubljana Slovenia www.radioloncol.com research article 341 The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer Erik Škof 1, Sebastjan
More informationDepartment of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India 2
original article Oman Medical Journal [2016], Vol. 31, No. 3:165 169 Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx
More informationStudy of expression of P53 in Gastric Carcinoma As a prognostic indicator
Original Research Article Study of expression of P53 in Gastric Carcinoma As a prognostic indicator K. Padma Malini 1*, Srivani 2, O. Shravan Kumar 3 1 Assistant Professor, 2 Associate Professor, 3 Professor
More informationRare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital
E-Da Medical Journal 20;():-5 Original Article Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital Wei-Ting Kuo, I-Wei Chang2, Kevin Lu, Hua-Pin Wang, Tsan-Jung u, Victor C.
More informationThe prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study
Received: 21 September 2017 Accepted: 22 January 2018 DOI: 10.1002/pros.23492 ORIGINAL ARTICLE The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective
More informationGenetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology
Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Outline Germline testing CDKN2A BRCA2 BAP1 Somatic testing Gene expression profiling (GEP) BRAF Germline vs Somatic testing
More informationFDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationIs Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationEvolution of Pathology
1 Traditional pathology Molecular pathology 2 Evolution of Pathology Gross Pathology Cellular Pathology Morphologic Pathology Molecular/Predictive Pathology Antonio Benivieni (1443-1502): First autopsy
More informationPh.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE Ph.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY SCIENTIFIC COORDINATOR: PROF. DR. MIHAI B. BRĂILA, Ph.D. Ph.D. Graduand:
More informationPrognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
Hou et al. World Journal of Surgical Oncology (2018) 16:198 https://doi.org/10.1186/s12957-018-1504-5 REVIEW Open Access Prognostic significance of metastatic lymph node ratio: the lymph node ratio could
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationTumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma
ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI
More information